Literature DB >> 24530743

Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy.

Kerrie Vaughan1, Emily Seymour2, Bjoern Peters2, Alessandro Sette2.   

Abstract

The recent increase in whooping cough in vaccinated populations has been attributed to waning immunity associated with the acellular vaccine. The Immune Epitope Database (IEDB) is a repository of immune epitope data from the published literature and includes T cell and antibody epitopes for human pathogens. The IEDB conducted a review of the epitope literature, which revealed 300 Bordetella pertussis-related epitopes from 39 references. Epitope data are currently available for six virulence factors of B. pertussis: pertussis toxin, pertactin, fimbrial 2, fimbrial 3, adenylate cyclase and filamentous hemagglutinin. The majority of epitopes were defined for antibody reactivity; fewer T cell determinants were reported. Analysis of available protective correlates data revealed a number of candidate epitopes; however few are defined in humans and few have been shown to be protective. Moreover, there are a limited number of studies defining epitopes from natural infection versus whole cell or acellular/subunit vaccines. The relationship between epitope location and structural features, as well as antigenic drift (SNP analysis) was also investigated. We conclude that the cumulative data is yet insufficient to address many fundamental questions related to vaccine failure and this underscores the need for further investigation of B. pertussis immunity at the molecular level.
Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24530743      PMCID: PMC4792526          DOI: 10.1016/j.humimm.2014.02.013

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  61 in total

Review 1.  The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.

Authors:  John B Robbins; Rachel Schneerson; Birger Trollfors; Hiroko Sato; Yuji Sato; Rino Rappuoli; Jerry M Keith
Journal:  J Infect Dis       Date:  2004-11-30       Impact factor: 5.226

2.  Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies.

Authors:  María Eugenia Rodríguez; Sandra M M Hellwig; María L A Pérez Vidakovics; Guy A M Berbers; Jan G J van de Winkel
Journal:  FEMS Immunol Med Microbiol       Date:  2006-02

3.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Authors:  J Storsaeter; H O Hallander; L Gustafsson; P Olin
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

4.  Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children.

Authors:  Julie Rowe; Stephanie T Yerkovich; Peter Richmond; Devinda Suriyaarachchi; Elizabeth Fisher; Leonie Feddema; Richard Loh; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

Authors:  M Ryan; G Murphy; E Ryan; L Nilsson; F Shackley; L Gothefors; K Oymar; E Miller; J Storsaeter; K H Mills
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

6.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells.

Authors:  M Ryan; G Murphy; L Gothefors; L Nilsson; J Storsaeter; K H Mills
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

8.  A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.

Authors:  J D Cherry; J Gornbein; U Heininger; K Stehr
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

9.  The cellular immune response to Bordetella pertussis in two children with whooping cough.

Authors:  J P Hafler; A Pohl-Koppe
Journal:  Eur J Med Res       Date:  1998-11-17       Impact factor: 2.175

10.  Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.

Authors:  B P Mahon; B J Sheahan; F Griffin; G Murphy; K H Mills
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  15 in total

1.  The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.

Authors:  Andrew Preston
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

2.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

3.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.

Authors:  Tara Bancroft; Myles B C Dillon; Ricardo da Silva Antunes; Sinu Paul; Bjoern Peters; Shane Crotty; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Cell Immunol       Date:  2016-05-14       Impact factor: 4.868

4.  The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.

Authors:  Jamie Jennings-Gee; Sally Quataert; Tridib Ganguly; Ralph D'Agostino; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

5.  Differences in epitope-specific antibodies to pertussis toxin after infection and acellular vaccinations.

Authors:  Aapo Knuutila; Tine Dalby; Alex-Mikael Barkoff; Charlotte Sværke Jørgensen; Kurt Fuursted; Jussi Mertsola; Kevin Markey; Qiushui He
Journal:  Clin Transl Immunology       Date:  2020-08-02

Review 6.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs.

Authors:  John A Ellis; Sheryl P Gow; Lindsey B Lee; Stacey Lacoste; Eileen C Ball
Journal:  Can Vet J       Date:  2017-08       Impact factor: 1.008

8.  Genomic analysis of a Mycobacterium bovis bacillus [corrected] Calmette-Guérin strain isolated from an adult patient with pulmonary tuberculosis..

Authors:  Xuming Li; Liping Chen; Yongqiang Zhu; Xia Yu; Jun Cao; Rui Wang; Xinyan Lv; Jin He; Aizhen Guo; Hairong Huang; Huajun Zheng; Siguo Liu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 9.  A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis.

Authors:  Yuan Tian; Ricardo da Silva Antunes; John Sidney; Cecilia S Lindestam Arlehamn; Alba Grifoni; Sandeep Kumar Dhanda; Sinu Paul; Bjoern Peters; Daniela Weiskopf; Alessandro Sette
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 10.  Roads to the development of improved pertussis vaccines paved by immunology.

Authors:  Jolanda Brummelman; Mieszko M Wilk; Wanda G H Han; Cécile A C M van Els; Kingston H G Mills
Journal:  Pathog Dis       Date:  2015-09-06       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.